CD109 (CD109 molecule)
2011-08-01 Shinji Mii  , Yoshiki Murakumo  , Masahide Takahashi   AffiliationDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
Identity
HGNC
LOCATION
6q13
LOCUSID
ALIAS
CPAMD7,p180,r150
FUSION GENES
DNA/RNA

Exon-intron structure of CD109 gene. The vertical bars correspond to exons.
Description
CD109 is a gene of 132.53 kb comprising 33 exons and 32 introns. The 5 part of exon 1 and the 3 part of exon 33 are non-coding.
Transcription
Three splice variants are known. The length of the longest variant is 9464 bp (CDS: 426-4763). mRNA is mainly expressed in skin and testis.
Pseudogene
Not known.
Proteins

Representation of the CD109 protein with localization of recognized domains. CD109 protein is a GPI-anchored protein having signal peptide, Gov antigen, thioester region, and furinase cleavage site.
Description
CD109 is a GPI-anchored cell-surface glycoprotein and is a member of the alpha-2-macroglobulin/C3,C4,C5 family of thioester-containing proteins (Sutherland et al., 1991; Haregewoin et al., 1994; Smith et al., 1995; Lin et al., 2002). The CD109 protein was first identified as a cell-surface antigen detected by a monoclonal antibody raised against the primitive lymphoid/myeloid cell line KG1a (Sutherland et al., 1991). It was also shown that CD109 carries the biallelic platelet-specific alloantigen Gov (Kelton et al., 1990; Smith et al., 1995).
Expression
CD109 is expressed on a subset of fetal and adult CD34+ bone marrow mononuclear cells, mesenchymal stem cell subsets, phytohemagglutinin (PHA)-activated T lymphoblasts, thrombin-activated platelets, leukemic megakaryoblasts, endothelial cells, and some human tumor cell lines, but not on fresh peripheral leukocytes and normal bone marrow leukocytes (Kelton et al., 1990; Murray et al., 1999; Giesert et al., 2003).
In normal human tissues other than hematopoietic cells, CD109 is expressed in limited cells including the myoepithelial cells of the mammary, lacrimal, salivary and bronchial glands and the basal cells of the prostate and the bronchial epithelia (Hashimoto et al., 2004; Zhang et al., 2005; Sato et al., 2007; Hasegawa et al., 2007; Hasegawa et al., 2008).
Recently, it has been reported that CD109 is highly expressed in several types of human cancer tissues, in particular squamous cell carcinomas (Hashimoto et al., 2004; Zhang et al., 2005; Sato et al., 2007; Hasegawa et al., 2007; Hasegawa et al., 2008; Järvinen et al., 2008; Hagiwara et al., 2008; Ohshima et al., 2010; Hagikura et al., 2010).
In normal human tissues other than hematopoietic cells, CD109 is expressed in limited cells including the myoepithelial cells of the mammary, lacrimal, salivary and bronchial glands and the basal cells of the prostate and the bronchial epithelia (Hashimoto et al., 2004; Zhang et al., 2005; Sato et al., 2007; Hasegawa et al., 2007; Hasegawa et al., 2008).
Recently, it has been reported that CD109 is highly expressed in several types of human cancer tissues, in particular squamous cell carcinomas (Hashimoto et al., 2004; Zhang et al., 2005; Sato et al., 2007; Hasegawa et al., 2007; Hasegawa et al., 2008; Järvinen et al., 2008; Hagiwara et al., 2008; Ohshima et al., 2010; Hagikura et al., 2010).
Localisation
Plasma membrane.
Function
CD109 negatively regulates TGF-beta signaling in keratinocytes by directly modulating TGF-beta receptor activity in vitro (Finnson et al., 2006).
Homology
Orthologs: mouse CD109, rat CD109, cow CD109, dog CD109, chicken CD109, hagfish CD109, nematode CD109.
Paralogs: alpha-2-macroglobulin, alpha-2-macroglobulin-like-1, C3, C4, C5, PZP, CPAMD8.
Paralogs: alpha-2-macroglobulin, alpha-2-macroglobulin-like-1, C3, C4, C5, PZP, CPAMD8.
Mutations
Note
A Tyr703Ser polymorphism of CD109 is associated with Gova and Govb alloantigenic determination (Schuh et al., 2002).
Implicated in
Entity name
Various cancer
Note
CD109 is upregulated in squamous cell carcinomas (SCCs) of lung, esophagus, uterus and oral cavity, malignant melanoma of skin, and urothelial carcinoma of urinary bladder (Hashimoto et al., 2004; Zhang et al., 2005; Sato et al., 2007; Hasegawa et al., 2007; Hasegawa et al., 2008; Järvinen et al., 2008; Hagiwara et al., 2008; Ohshima et al., 2010; Hagikura et al., 2010).
Prognosis
The CD109 expression is significantly higher in well-differentiated SCCs of the oral cavity and in low-grade urothelial carcinomas of the urinary bladder than in moderately- or poorly-differentiated SCCs and in high-grade urothelial carcinomas, respectively (Hagiwara et al., 2008; Hagikura et al., 2010).
Entity name
Alloimmune thrombocytopenic syndromes
Note
Refractoriness to platelet transfusion, post-transfusion purpura, and neonatal alloimmune thrombocytopenia (Smith et al., 1995).
Disease
These diseases are included in alloimmune thrombocytopenic syndromes. Gova/b platelet alloantigens, which reside in the CD109 protein, are the cause of these 3 diseases.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 16754747 | 2006 | Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. | Finnson KW et al |
| 12799300 | 2003 | Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsets. | Giesert C et al |
| 20946523 | 2010 | Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression. | Hagikura M et al |
| 19016750 | 2008 | Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. | Hagiwara S et al |
| 8025953 | 1994 | Cellular expression of a GPI-linked T cell activation protein. | Haregewoin A et al |
| 18429827 | 2008 | CD109 expression in basal-like breast carcinoma. | Hasegawa M et al |
| 15116102 | 2004 | Expression of CD109 in human cancer. | Hashimoto M et al |
| 18314910 | 2008 | High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. | Järvinen AK et al |
| 2346781 | 1990 | Gova/b alloantigen system on human platelets. | Kelton JG et al |
| 11861284 | 2002 | Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins. | Lin M et al |
| 10428505 | 1999 | CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells. | Murray LJ et al |
| 20034764 | 2010 | CD109 expression levels in malignant melanoma. | Ohshima Y et al |
| 17922683 | 2007 | High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. | Sato T et al |
| 11861285 | 2002 | A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. | Schuh AC et al |
| 7670116 | 1995 | Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. | Smith JW et al |
| 1984805 | 1991 | Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets. | Sutherland DR et al |
| 15826242 | 2005 | CD109 expression in squamous cell carcinoma of the uterine cervix. | Zhang JM et al |
Other Information
Locus ID:
NCBI: 135228
MIM: 608859
HGNC: 21685
Ensembl: ENSG00000156535
Variants:
dbSNP: 135228
ClinVar: 135228
TCGA: ENSG00000156535
COSMIC: CD109
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000156535 | ENST00000287097 | Q6YHK3 |
| ENSG00000156535 | ENST00000422508 | Q6YHK3 |
| ENSG00000156535 | ENST00000437994 | Q6YHK3 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36929132 | 2023 | CD109-regulated mechanical properties of endothelial cells. | 0 |
| 37030166 | 2023 | Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling. | 0 |
| 37373457 | 2023 | CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis. | 2 |
| 37661780 | 2023 | H3K27 acetylation activated-CD109 evokes 5-fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway. | 0 |
| 36929132 | 2023 | CD109-regulated mechanical properties of endothelial cells. | 0 |
| 37030166 | 2023 | Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling. | 0 |
| 37373457 | 2023 | CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis. | 2 |
| 37661780 | 2023 | H3K27 acetylation activated-CD109 evokes 5-fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway. | 0 |
| 34743190 | 2022 | The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β. | 6 |
| 34762199 | 2022 | CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. | 1 |
| 35347029 | 2022 | The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma. | 0 |
| 35385222 | 2022 | Placental and plasma early predictive biomarkers for gestational diabetes mellitus. | 2 |
| 34743190 | 2022 | The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β. | 6 |
| 34762199 | 2022 | CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. | 1 |
| 35347029 | 2022 | The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma. | 0 |
Citation
Shinji Mii ; Yoshiki Murakumo ; Masahide Takahashi
CD109 (CD109 molecule)
Atlas Genet Cytogenet Oncol Haematol. 2011-08-01
Online version: http://atlasgeneticsoncology.org/gene/42925/cd109
